Basic Study
Copyright ©The Author(s) 2024.
World J Gastrointest Oncol. Jul 15, 2024; 16(7): 3284-3298
Published online Jul 15, 2024. doi: 10.4251/wjgo.v16.i7.3284
Figure 5
Figure 5 Validation of high canopy FGF signaling regulator 3 expression. A: Relative mRNA expression levels of canopy FGF signaling regulator 3 (CNPY3) in normal (HCoEpiC and NCM460) and cancer cell lines (Caco-2, HCT-116, HT-29, SW48, SW480, and SW620); B: Relative mRNA expression levels of CNPY3 in normal tissue, tumor tissue, and tumor cell lines; C: Differences in immunohistochemical scores; D: Representative immunohistochemical staining images of normal tissue; E: Representative immunohistochemical staining images of tumor tissue. aP < 0.05; bP < 0.01, cP < 0.001. CNPY3: Canopy FGF signaling regulator 3; COAD: Colon adenocarcinoma.